Related by context. All words. (Click for frequent words.) 81 loss carryforward 77 operating loss carryforwards 72 NOLs 71 carryforwards 69 loss carryovers 69 NOL carryforwards 66 carryforward 61 NOL carryforward 60 valuation allowance 59 asset valuation allowance 58 valuation allowances 58 credit carryforwards 58 loss carrybacks 57 carryback 57 unrealized derivative gains 56 OTTI charges 56 NOL utilization 56 substantively enacted 56 realizability 55 loss NOL carryforward 55 Stendal mill 55 reinsurance commutations 55 asset monetizations 55 OTTI charge 54 carrybacks 54 Filtran Microcircuits Inc. 54 d Represents 54 undistributed earnings 54 accretable yield 54 adopting SFAS #R 53 undepreciated 53 debt extinguishments 53 Visa indemnification 53 No. #R 53 accounts receivable balances 53 marketable securities 53 unconsolidated investee 52 depreciable assets 52 DAC unlock 52 temporary impairments OTTI 52 uncollectible accounts receivable 52 Lifecomm Joint Venture 52 receivable balances 52 Rosebel royalty 52 unrealized depreciation 52 loss carryback 52 OPEB expense 52 reasonably estimable 52 taxable income 52 unitholder distributions 52 hedge ineffectiveness 52 intercompany loans 51 unrealized hedging 51 unevaluated properties 51 GSCT program 51 OTTI write downs 51 Section #/#K 51 operatingincome 51 c Represents 51 unrealized losses 51 noncash impairments 51 PGP Acquisition 51 nondeductible expenses 51 LIFO inventory valuation 51 RAPTIVA R 50 undistributed taxable income 50 TASE EVGN.TA 50 netincome 50 b Relates 50 GMDB 50 CAD#m [002] 50 estimated undiscounted 50 discontinued operations 50 ReHo 50 Adjusted EBITDA excludes 50 escrowed funds 50 addback 50 stock basedcompensation 50 FDIC indemnification 50 nondividend distribution 50 RRSP contribution room 50 Cortelco 50 unrealized gains 50 Kereco 50 foreign currency remeasurement 50 Hardwoods LP 50 establishing valuation allowance 50 Thomas Regout operations 50 Canbras 50 undrawn revolver 50 LIFO adjustment 49 depletable 49 unrealized appreciation 49 remeasurement 49 Mowood 49 Gosman Estate 49 goodwill impairment charge 49 adopted SFAS #R 49 c Calculated 49 FAFLIC 49 pension curtailment 49 postretirement benefit 49 currency remeasurement 49 retroactive reinstatement 49 nonrecurring expenses 49 exchangeable debentures 49 reinsurance recoverables 49 #.# perdiluted 49 SIFT Tax 49 Senior Secured Term 49 accruals 49 iv GTx 49 depreciation accretion 49 EURO#.# [002] 49 forwards NOLs 49 unrealized derivative 49 ofapproximately 49 DAC unlocking 49 AcG 49 unamortized portion 48 unrealized derivative losses 48 exclude noncash 48 f Represents 48 unvested options 48 indemnification obligations 48 LIFO accounting 48 voluntary prepayment 48 actuarially determined 48 accretion expense 48 accumulated undistributed 48 Cobalt Gordian 48 accrual reversal 48 Vishay stockholders 48 Pro forma adjusted EBITDA 48 NETg acquisition 48 defeased loans 48 uncollectable receivables 48 aftertax 48 PFICs 48 hydrovac units 48 cash flows 48 impairment charges 48 intangible assets impairment 48 doubtful accounts receivable 48 intangible impairment 48 financialstatements 48 early extinguishments 48 intercompany indebtedness 48 LILO transactions 48 Note Receivable 48 franking credits attached 48 PFIC 48 QSBS 48 unrealized derivative gain 48 - -Sumi é Art 48 non recurring 48 exchangeable notes 48 Qualified Dividends 48 DiaMed acquisition 48 rebased amounts 48 Adjusted Earnings 48 FSAH acquisition 48 distributable earnings 48 Rosebel Royalty 48 IETU 48 actuarial liabilities 48 Petition Date 48 No. #R Share 47 USOGP 47 Xantic acquisition 47 Catastrophe losses 47 unfunded accrued 47 undistributed profits 47 Xantic 47 consolidated balance sheet 47 Lasertel subsidiary 47 postretirement benefits 47 NOL carryback 47 convertible subordinated notes 47 FDIC indemnification asset 47 per dilutedshare 47 unrealized gain 47 millioncompared 47 MSR impairment 47 Dualam 47 infrequently occurring 47 Symphony GenIsis 47 noncash goodwill 47 commodity derivative instruments 47 f Reflects 47 cash equivalents marketable securities 47 Surface Specialties acquisition 47 receivables securitization 47 condensed consolidated balance sheet 47 Endo Pharma LLC 47 Hedge ineffectiveness 47 refranchising transactions 47 accrual 47 normalized FFO 47 FSAH Acquisition 47 noncash pretax charge 47 ended September# 47 Operational EBITDA 47 LIFO inventory 47 deductible goodwill impairment 47 Rhein Biotech NV 47 Hardwoods USLP 47 Specified Investment 47 undrawn revolving credit 47 balance sheet deleveraging 47 reinstatement premiums 47 ROACE 47 CICA Section 47 affiliate Evogene Ltd. www.evogene.com 47 ninemonths ended 47 CGAAP 47 IBNR reserves 47 accelerated depreciation 47 nonoperating expense 47 MDP Transaction 47 Tax Attributes 47 VIOXX Lawsuits 47 nondeductible portion 47 Subordinate MBS 47 intersegment transactions 47 Combined Entity 47 calculating FFO 47 recharacterization 47 amortization expense 47 FAS# R 47 LGP Allgon 47 inventories revalued 47 VIEs 47 - Adjusted [028] 47 Canexus LP 47 temporary impairments 47 LIFO adjustments 47 nonrecurring items 47 pretax noncash 47 REIT Exemption 47 Oxy ER 47 adopting SFAS 47 Crisa acquisition 47 ELIOKEM 47 EMEA Subsidiaries 47 postretirement benefit plans 47 contractual minimums 46 Filtertek 46 unbooked resource potential 46 unamortized deferred 46 Arana Therapeutics Limited 46 Hedging Relationships AcG 46 aC corporation 46 items affecting comparability 46 operating income1 46 policyholder dividends 46 recourse indebtedness 46 LAE reserves 46 profi ts 46 ceding commissions 46 Senior Exchangeable Notes 46 adjusted distributable cash 46 Chemicals Segment 46 adjusted EBITDAR 46 retrospectively adjusted 46 indebtedness incurred 46 Delvag Rueck 46 Eur #,# 46 unfavorable variances 46 GLJ Report 46 goodwill intangible 46 nonforfeitable 46 Medicare Advantage PFFS 46 depreciable asset 46 imputation credits 46 depreciable real estate 46 BPSAG 46 COLI policies 46 MFB Corp 46 QTDP Program 46 consolidated VIEs 46 ceded reinsurance 46 FSP #-# 46 antidilutive 46 securitized receivables 46 Partnered Brands segment 46 Convertible Debt 46 thetransaction 46 SFAS #R 46 intercompany receivables 46 Valuation allowance 46 underwriting discounts commissions 46 intercompany eliminations 46 Brooks Eckerd acquisition 46 REITs FFO 46 recharacterized 46 Reclassification adjustment 46 Valhi stockholders 46 nonrecurring 46 undrawn commitments 46 ARIF II 46 receivable 46 antibody humanization patents 46 TA Cogen 46 NPREIT 46 FASB Interpretation No. 46 Zero Coupon Convertible Notes 46 Transsib Re 46 SBIC leverage 46 amortizable 46 REIT taxable 46 Pro forma Adjusted EBITDA 46 NMHG Retail 46 unbilled revenue 46 contingently convertible securities 46 European windstorm Xynthia 46 Valeant stockholders 46 translation adjustment 46 intangible impairments 46 c Relates 46 loan chargeoffs 46 nondeductible 46 EUR -#.# -#.# [001] 46 FSP APB #-# 46 Cleartel 46 LIFO expense 46 profitsharing 46 disqualifying dispositions 46 EPE unitholders 46 asset impairments 46 Celgar mill 46 excluding AOCI 46 ASC #-# 46 severance accruals 46 Cash Flow Swap 46 reinsurance recoveries 46 Sofora Telecomunicaciones SA 46 MNOK #.# 46 BioGlue ® 46 EURO#.# [001] 46 accounts receivable securitization 46 - - Net [007] 46 Unlevered Cash Flow 46 FIN #R Consolidation 46 Airesurf 46 EdgeStone Funds 46 Futureway Communications Inc. 46 Income Taxes 46 #,#,# #,#,# Deferred [001] 46 tax Impuesto Empresarial 46 Ps.6 46 MtM gains 46 EBIAT 46 EnPro consolidated 45 impairment charge 45 invoiced shipment 45 trust preferreds 45 RUB#.#bn [002] 45 MDS Proteomics 45 Remainco 45 MFFO 45 noncash accounting 45 TOBs 45 #.#per diluted 45 Pro forma adjustments 45 SFAS No.# 45 Corus Aluminum 45 junior subordinated debentures 45 Qualcomm Strategic Initiatives 45 Interest expense decreased 45 amortize goodwill 45 DXL TM antibodies 45 Magna Racino TM 45 Folksamerica 45 c Reflects 45 Optim Energy 45 revolver borrowings 45 goodwill impairment 45 -Gottron 45 depletion depreciation 45 b Excludes 45 EBDDT 45 LIFO liquidation 45 intangible asset impairments 45 LIQUIDITY AND 45 depreciation 45 convertible exchangeable 45 Merged Entity 45 Embedded Derivatives 45 Excluding nonrecurring items 45 convertible subordinated debentures 45 Domilens 45 balance sheet securitizations 45 THALOMID 45 -Edelsberg 45 INOVA Geophysical 45 calculating distributable cash 45 Unizan merger 45 Ps.7 45 SemCanada Crude 45 Notes LYONs 45 TSX GVC 45 distort comparability 45 noncurrent liabilities 45 CAPITAL RESOURCES 45 UBTI 45 DIP Financing 45 grantor trust 45 Accounting Guideline 45 share repurchase authorizations 45 noninterest expense decreased 45 sale leaseback transaction 45 marketable securities totaled 45 dollar denominated debenture 45 CTVgm 45 nonoperating items 45 Sovello AG 45 Assumed provision 45 enacted Patient Protection 45 depreciation depletion amortization 45 ATCF 45 SFSB Inc. 45 CICA Handbook section 45 Issuing MTP helps 45 deductibility 45 intercompany balances 45 Equity Investees 45 SIFT Rules 45 #.#/diluted share 45 Novogyne 45 subordinated convertible notes 45 Standardized Measure 45 undistributed net 45 FASB Statement #R 45 FSP EITF #-#-# [002] 45 retrocessions 45 Deferred Income Tax 45 Noninterest expense decreased 45 Contingent Consideration 45 PNOI 45 Hedging Relationships 45 franking credits 45 FSP FAS #-# 45 Acergy Piper 45 Asset Retirement Obligation 45 TEB adjustment 45 Discontinued Operations 45 EUR# mn [001] 45 hedging derivative instruments 45 Ps.3 45 Bonterra Trust 45 Exploration Expense 45 noncontrolling interest 45 Regulation XXX 45 OPANA ER 45 FAS #R 45 intercompany 45 mandatorily redeemable 45 nonGAAP 45 Kingsway Reinsurance Corporation 45 elective deferrals 45 QSI segment 45 Amounts Unaudited 45 Tenovis 45 FFO FAD 45 realizable value 45 Reports Wider 45 Order Backlog 45 - NeDEFENDERS 45 decedents dying 45 debt paydown 45 Shurgard Europe 45 - CASH FLOWS [012] 45 taxable REIT 45 European Windstorm Xynthia 45 No. #R SFAS 45 n#.# [002] 45 EUR #,# Mio 45 Inc. OTC CDCO 45 OSIs 45 -disc protrusion 45 convertible notes 44 earnings pershare 44 ratably 44 disallowance 44 FSAH 44 depreciation amortization depletion 44 SFSB transaction 44 SFAS# R 44 impaired OTTI 44 DPSPs 44 ASC Topic #-# 44 borrowable resources 44 adopting IFRS 44 - Adjusted [030] 44 investees partially offset 44 liabilities 44 TYN 44 Exterran Holdings indirectly 44 Resource Surcharge 44 depletable base 44 earnout payment 44 unabsorbed overhead 44 Panamax Bulk Carrier 44 - - Income [020] 44 Avenir Trust 44 Applied Magnesium International 44 noncash goodwill impairment 44 noncurrent assets 44 Applied Magnesium 44 nonoperating expenses 44 repurchases 44 accretable 44 #R Share Based 44 Consolidated OIBDA 44 - - Net [047] 44 undiscounted cash 44 expenses totaled Ps 44 undepreciated assets 44 LIFO inventory adjustments 44 includible 44 IRC § 44 PLAVIX R 44 Real Estate Owned OREO 44 Innovis Entities 44 UNII Balance Average 44 depletion calculation 44 Pigments segment 44 Non Controlling Interests 44 OTTI 44 amortizable intangible assets 44 Comparable FFO 44 ASC Subtopic #-# 44 aftertax gain 44 ADSI reliance 44 Discontinued Operation 44 Senior Convertible Notes 44 liquidating distributions 44 consolidated OIBDA 44 SWDCC 44 promissory note receivable 44 Contingent Convertible Notes 44 PNMR 44 pro forma EBITDA 44 NONRECURRING ITEMS 1 44 j Includes 44 SBLIC 44 aftertax charge 44 RASP Data Security 44 unamortized issuance costs 44 Westshore Terminals Limited 44 USD#.#m USD#.# per [002] 44 b Computed 44 Lordsburg Mining District 44 postretirement benefit expense 44 QUALCOMM pro forma 44 EGI Financial 44 Debt Extinguishment 44 FIFO inventory 44 SIFTs 44 accounts receivable 44 reinsurance commutation 44 Consolidated EBITDAR 44 - SegmentPrincess Dina Mired 44 CompX 44 unamortised 44 prepetition liabilities 44 OCF margin 44 standardized distributable cash 44 anduncertainties 44 eV PRODUCTS 44 Individual Annuities segment 44 Verestar 44 reestimates 44 DJO Merger 44 OPEB liability 44 LSV Employee Group 44 convertible promissory notes 44 AMF Ultra Short 44 Crisa 44 Guaranteed Minimum Withdrawal Benefit 44 Unrealized derivative 44 PMPS brand 44 Tasa Unica 44 compensation expense 44 -Alcampo 44 Predecessor Period 44 unsecured debenture 44 nonconvertible debt 44 GMIB 44 FRBNY Credit Facility 44 unamortized premiums 44 -DD2 44 MCLP 44 perpetual debentures 44 asset impairment 44 LibertyBank Acquisition 44 unproved leasehold 44 NETAPP INC. CONDENSED CONSOLIDATED 44 voluntary prepayments 44 Azactam 44 Contingent Value Right 44 Asset Impairment Charge 44 taxpayer itemizes deductions 44 Petrojarl Varg FPSO 44 accompanying unaudited consolidated 44 BOLI COLI 44 LIFO inventory decrement 44 Therics LLC 44 Final Liquidating Distribution 44 diluted share 44 - Weighted average [004] 44 QUALCOMM Strategic Initiatives 44 Promotions.com subsidiary 44 - - Nforecaddie 44 unfavorable variance 44 fiscal# 44 - - Net [003] 44 Doubtful Accounts 44 MEP Joint Venture 44 continuingoperations 44 unsecured debentures 44 BPE Segment 44 Jiantou Xinyuan 44 Aleris Holding 44 Ptek 44 Maritech 44 redomestication 44 #compared 44 CICA Accounting Guideline 44 - INCOME LOSS [001] 44 Repurchased shares 44 Cashflows 44 normalized FFO guidance 44 JLG acquisition 44 Klean Prep TM 44 excludes depreciation amortization 44 Performance Polymers segment 44 unconsolidated investees 44 uncollectible receivable 44 BPLP 44 HNTE 44 EIFH 44 deductible IRAs 44 Roth IRA withdrawals 44 intangible asset 44 Tax Expense 44 financialperformance 44 prioryear 44 FAS #R Share 43 % Convertible Subordinated 43 Harland Acquisition 43 Fund TSX VIC.UN 43 pretax goodwill impairment 43 FNLC 43 taxable equivalent FTE 43 Business Combinations 43 Accelerated Depreciation 43 Ms. Bouvette 43 repay indebtedness 43 Derivative instruments 43 decremental 43 solvency deficiency 43 millionin 43 Asset Retirement Obligations 43 netsales 43 HSR clearance 43 Senior Secured Revolving Credit 43 Share repurchases 43 nonaccrual loan 43 Gujiao facility 43 excluding depreciation depletion 43 SunPower incurs amortization 43 Varvarinskoye Project 43 SIFT Legislation 43 identifiable intangible assets 43 deconsolidation 43 Value Creation Plan 43 noncash charge 43 postretirement benefit obligations 43 Equinix excludes 43 Essentis 43 OPANA franchise 43 subordinated debentures 43 MSEK -#.# 43 BioMarin Genzyme LLC 43 antidilution 43 divestitures 43 leaseback transactions 43 equity accounted investees 43 Olefins Polyolefins 43 - - [054] 43 postretirement obligations 43 SBIC debentures 43 currency translation 43 FINOVA 43 Paperboard Packaging segment 43 withholdable payment 43 accrual reversals 43 CDFS dispositions 43 Hedging Activities 43 OREO valuation 43 worth #mln rub 43 Oxandrin 43 DSUs 43 borrowable funds 43 ABCP holdings 43 Commodity Margin 43 Proved undeveloped reserves 43 AOCL 43 meaningful supplemental 43 Barrett NDEx 43 adopting FIN 43 Katonah Debt Advisors 43 deconsolidating 43 rebased revenue 43 covenant calculations 43 assessable income 43 FIN #R 43 Possible Loan Losses 43 noncash 43 Act AJCA 43 temporary impairment OTTI 43 Marbob acquisition 43 Oy Ovako Ab 43 THE JEAN COUTU 43 FFO payout ratio 43 MTP Shares 43 Payment FAS #R 43 LIFO method 43 flow hedges 43 EBDT 43 asset impairments restructuring 43 Adjusted EBIT 43 OnVista Group 43 - - NetMarigot Bay r 43 - Adjusted [016] 43 unrealized 43 Martison Project 43 LTCG 43 Geomark 43 FIFO method 43 Mavrix Mutual Funds 43 derivative instrument 43 Adjusted EBIDTA 43 senior unsecured debentures 43 intangible assets 43 goodwill impairments 43 Flow Through SIFT 43 Reconciling Items 43 Cortelco Shanghai 43 Xylodyne 43 Impairment Losses 43 capital expenditures 43 Company noncontributory defined 43 CIP FENOFIBRATE 43 CAD#.# billion 43 unamortized financing 43 Ps.2 43 GBP# GBP# GBP# GBP# 43 ONEOK Partners segment 43 SEK -#.# -#.# [003] 43 non recourse RISPERDAL 43 Unitholder distributions 43 AGCS AG 43 LIFO reserve 43 unamortized 43 noncash pretax 43 AGY Asia 43 Visa MasterCard antitrust 43 RDSPs 43 balance sheet 43 4Q FY# 43 Income Tax Expense 43 Impairment Charge 43 IRA withdrawals 43 Contingent Value Rights 43 Non GAAP Diluted EPS 43 inventory obsolescence 43 SCNI 43 Bois d' Arc's 43 Traditional IRAs 43 Astaris joint venture 43 excluding goodwill impairment 43 unconsolidated affiliate 43 Extendicare Limited 43 Adjusted EBITDAX 43 nonroutine income 43 EDCI 43 Teekay Parent 43 IREX joint venture 43 unrealized gains losses 43 dacetuzumab collaboration 43 QCRH 43 explanatory paragraph indicating 43 worth #.#bn rub [001] 43 FHLBNY advances 43 Lagunas Norte Pierina 43 - - Net [051] 43 securitization trusts 43 AvenEx 43 SMTEK 43 Eligard R 43 Evaporative Cooling segment 43 goodwill writedown 43 Unfunded pension 43 ACTIVEnergy Income Fund 43 Nemak transaction 43 Canaccord Relief Program 43 Delvag 43 ABL Facility 43 CASH FLOWS PROVIDED BY 43 Retirement Obligations 43 Zero Coupon Convertible Subordinated 43 Jevco Insurance Company 43 COGP 43 ended December# 43 SFAS 43 securitized accounts receivable 43 Renegy 43 SEK #,#,#,# 43 Standardized distributable cash 43 c Consists 43 postretirement benefit OPEB 43 Nonoperating 43 opportunistically repurchase 43 TOLL BROTHERS INC. AND 43 ASC #-#-# 43 MSEK -# [001] 43 modestly accretive 43 construction AFUDC 43 -SIFs 43 Gaz Métro inc 43 Significant Items 43 successfully integrate Legerity 43 SigmaKalon acquisition 43 Adjusted OIBA 43 Acquiree 43 dilutive securities 43 nonoperating 43 NeedleTech 43 Financing Transactions 43 - Adjusted [017] 43 amortisations 43 Wajax Income Fund 43 Tomi Mine 43 QSI segment certain 43 b Reflects 43 MSEK -# [002] 43 Patria Re 43 Items excluded 43 TRANSACTIONS WITH RELATED PARTIES 43 NTIC consolidated 43 American Jobs Creation 43 SFAS No. 43 Atrium Biotechnologies 43 Pro forma net 43 reinvestments 43 Flexpipe 43 Extraordinary Item 42 Telecomunicaciones de Puerto Rico 42 patented Bioral cochleate technology 42 inherited IRAs 42 AJCA 42 Therics 42 EITF #-# [001] 42 Mezzanine Loan 42 - NET LOSS [008] 42 Repurchase Program 42 pretax 42 Fully Taxed EPS 42 principal paydowns 42 identifiable intangibles 42 Huawei 3Com joint venture 42 nonperforming loans totaled 42 MZT Holdings 42 LPT Agreement 42 flowthrough 42 CompAir acquisition 42 non capitalizable 42 Cheneys owed 42 Non GAAP adjusted EBITDA 42 TSX GDI.UN 42 Mowood LLC 42 divestiture 42 RCF expiring 42 Foreign Currency Translation 42 redeemable preferred stock 42 Profile Research AMXL.MX Quote 42 accretively 42 Distributable Income 42 unamortized discount 42 CDFS 42 Tranche B 42 Acquired Intangible Assets 42 Windstorm Xynthia 42 materially impair 42 Variable Interest Entities VIEs 42 uncollectible receivables 42 Loan Payable 42 consolidated VIE 42 MIBRAG 42 Term Facility 42 IRC Sec 42 Previously Securitized Loans 42 retroactive restatement 42 AOCI 42 MTI PolyFab 42 convertible debentures 42 Appreciation Rights 42 cash fl ows 42 noncash impairment charge 42 g Represents 42 LYONs 42 OxyVinyls 42 Ratio BCAR 42 NAREIT definition 42 applied prospectively 42 FFO Measures 42 metric signaling 42 liquidate REO 42 NASDAQ SAMAS 42 NextRx pharmacy benefit 42 USPoly 42 Realised gains 42 #,# ADMTs 42 Realised Earnings 42 CypressTree 42 intersegment revenues 42 RRSP withdrawals 42 Provident Upstream 42 CCAA proceedings 42 Unilin segment 42 putable 42 specially serviced assets 42 promissory note payable 42 Revolving Credit Facilities 42 nonaccruing loans 42 months endedSeptember 42 acquired intangible assets 42 unabsorbed manufacturing 42 derivative liabilities 42 Xi'an Simo 42 - CaLou Smit 42 SFAS# 42 PsiNaptic 42 SEK -#.# [002] 42 Primelead 42 STCG 42 defease 42 upholstery fabrics segment 42 EnerCare 42 Hwada 42 IBNR 42 unitholders Unitholders 42 Rate differentials 42 Univeyor 42 nine monthsended 42 NLASCO 42 Stapled Unit 42 NYSE MIM MID 42 Pictou pulp mill 42 BCGI Shareholders 42 Century Indemnity 42 mandatorily redeemable preferred 42 reinsurance recoverable 42 Franke Mine 42 - Loss [019] 42 unconsolidated investments 42 #,# -BOB SANSEVERE 42 Including discontinued operations 42 #R Share 42 Policyholders dividends 42 Brascade Corporation 42 Unlevered free 42 convertible subordinated 42 Accurel 42 MMCFEPD 42 Copano commodity 42 amortization #,#,# 42 NOPAT 42 LIFO inventory accounting 42 NOL Protective Measures 42 AMEX Assurance 42 write offs 42 - - Net [043] 42 undeducted contributions 42 Position APB #-# 42 Zhejiang Yuhui 42 accrued liabilities #,#.# #,#.# 42 CHF4 42 -T#/T# 42 Accelerated Share Repurchase 42 BGSS 42 SEK #,#,#.# 42 Successor Period 42 rated MTP Shares 42 NYSE AGO Assured 42 intercompany transactions